SHARE

News Alert: Citius Pharmaceuticals Receives FDA Approval For LYMPHIR™ (Denileukin Diftitox-Cxdl) Immunotherapy For The Treatment Of Adults With Relapsed Or Refractory Cutaneous T-Cell Lymphoma. Click to Read More.

Axxess Pharma Inc (OTCMKTS:AXXE) announced that the company received approval from Nutrition House to offer its full range of Tapout products. Nutrition House is a leading health product franchise in Canada. The products will be available in more than sixty high profile shopping centers in Canada.

The details

The health product franchise of Canada determined Axxess Pharma’s Tapout product line, including protein shakes and Omega 3 Fish Oil supplements are an outstanding synergy for the health conscious customers. The franchise expects strong demand for the Axxess Tapout line, as more and more users become aware of the all-natural products available on their shelves.

The significance

Axxess Pharma selected a reputed company to extend its product reach in Canada. Nutrition House is famous all over Canada for offering the premium quality products to consumers. The product range consists of national brands of supplements, vitamins, sports nutrition products, body care as well as exclusive in-house additional products, and co-branded products, packaged solely for franchise by national brand suppliers.

The deal

This deal is part of Axxess Pharma’s strategic plan to continue the expansion of Tapout line into retail supermarket chains, shopping centers and pharmacies across the U.S. and Canada. The company continues to implement measures to expand globally forming association with leading natural health distributors.

The expert view

The management of Axxess Pharma said that they are honored to have the Tapout product line at Nutrition Health shelves, which is a reputed health product franchise in Canada. The deal expands Tapout product line into high traffic and high profile shopping centers spread throughout Canada. The company reported strong sales in Australia last year.

In last trading session, the stock price of Axxess Pharma surged more than 6% to close the trading session at $0.0780. The gains came at a share volume of 839,015 compared to an average share volume of 1.04 million.

SHARE
Previous articleCytoDyn Inc (OTCMKTS:CYDY) Submits Phase III Protocol to FDA
Next articleAlgae International Group Inc (OTCMKTS:ALGA) To Expand Beverage Line
Steve Kanaval: Portfolio Manager/Writer/ Market Analyst Steve began his career in the Trading Pits in Chicago making markets at the Chicago Mercantile Exchange (NYSE:CME) the Chicago Board of Trade and the CBOE in the early 80’s. He ran the Morgan Stanley Derivative Prop Trading for the firm specializing in Index Arbitrage. He continued his career as a Trader/Portfolio Manager for multiple Hedge Funds during the Internet Boom of the 90’s managing large portfolios. Steve is known as an expert in MicroCap Technology Stocks and the emerging Digital Currency markets as a Portfolio Manager for his Family Office. Steve has managed portfolio’s in volatile asset classes for 3 decades as a commodity trader, hedge fund manager and digital currency trader and miner. Steve publishes his views on the asset classes in a public forum and has published more than 10,000 articles simplifying these complex and volatile assets for readers. His work is published on multiple sites including Bloomberg, Equities.com, Hacked.com, CryptoCurrencyNews as a paid contributor. His work includes research, journalism and archived video on important market volatility related to stocks, digital currency and other volatile misunderstood asset classes. He offers a humorous, unique insight and the related back stories and drivers for readers interested in volatility and emerging market assets. Full disclosure Steve is long 25 digital currencies and sits on the board of multiple public companies involved in digital currencies, and owns shares in these companies from time to time.